Clinical Trials
3 trialsNCT03797326 2026-05-04
LEAP-005
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT05235737 2023-08-31
PIRG
Medical University of Silesia
Phase 4 Unknown
NCT02968940 2022-06-29
Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
NYU Langone Health
Phase 2 Completed